» Articles » PMID: 34155799

Current Management of NAFLD/NASH

Overview
Journal Liver Int
Specialty Gastroenterology
Date 2021 Jun 22
PMID 34155799
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

NAFLD is the most common cause of liver disease worldwide, and its prevalence is significantly increasing. Studies have shown that it is associated with comorbidities such as diabetes, metabolic syndrome and obesity. Early diagnosis and management are highly important and could modify the prognosis of the disease. Evaluating the possibility of multiple aetiologies and recognizing the additional causes of liver disease should be a part of the patient's initial assessment. There are no approved drug treatments as yet, so the main management strategies should involve lifestyle changes such as physical activity and dietary re-education.

Citing Articles

Pea Albumin Extracted from Pea ( L.) Seeds Ameliorates High-Fat-Diet-Induced Non-Alcoholic Fatty Liver Disease by Regulating Lipogenesis and Lipolysis Pathways.

Zhang S, Cui Z, Zhang H, Wang P, Wang F, Zhang J Nutrients. 2024; 16(14).

PMID: 39064674 PMC: 11280122. DOI: 10.3390/nu16142232.


A study on the treatment effects of polysaccharide on non-alcoholic fatty liver in mice by modulating gut microbiota.

Hao P, Yang X, Yin W, Wang X, Ling Y, Zhu M Front Vet Sci. 2024; 11:1383801.

PMID: 38601914 PMC: 11006196. DOI: 10.3389/fvets.2024.1383801.


Exercise training improves serum biomarkers of liver fibroinflammation in patients with metabolic dysfunction-associated steatohepatitis.

Harris S, Smith N, Hummer B, Schreibman I, Faust A, Geyer N Liver Int. 2023; 44(2):532-540.

PMID: 38014619 PMC: 10844956. DOI: 10.1111/liv.15769.


Pharmaceutical Strategies to Improve Druggability of Potential Drug Candidates in Nonalcoholic Fatty Liver Disease Therapy.

Amatya R, Lee D, Min K, Shin M Pharmaceutics. 2023; 15(7).

PMID: 37514148 PMC: 10386216. DOI: 10.3390/pharmaceutics15071963.


Low-Dose Administration of Cannabigerol Attenuates Inflammation and Fibrosis Associated with Methionine/Choline Deficient Diet-Induced NASH Model via Modulation of Cannabinoid Receptor.

Aljobaily N, Krutsinger K, Viereckl M, Joly R, Menlove B, Cone B Nutrients. 2023; 15(1).

PMID: 36615835 PMC: 9823433. DOI: 10.3390/nu15010178.